Department of Foreign Affairs (DFA) Secretary Teodoro Locsin Jr., has announced that the private sector will provide the country with the Russian-made Sputnik V Covid19 vaccine.
Sec. Locsin stated that he places full confidence solely in the Gamelayan Research Institute’s vaccine that, according to the peer reviewed, medical journal The Lancet, possesses a 91% effectivity rate.
The government intends to purchase 20 million doses of Sputnik V, to combat the Covid19 pandemic in the country.
Currently, there are only three vaccines that have been granted Emergency Use Authorization (EUA) in the country, by the Food and Drug Administration (FDA): Pfizer-BioNTech (US), Astrazeneca (UK), and recently, China’s Sinovac.
Due to the results of Sinovac’s clinical trials in Brazil which showed an effectivity rate of 50.4%, however, the FDA has not approved its use on Healthcare workers.
Meanwhile, local clinical trials for Belgium-based Janssen Pharmaceuticals’ own Covid19 vaccine have begun, according to the Department of Science and Technology (DOST), while China-based Clover Biopharmaceuticals’ local vaccine trials will begin soon, as well.